Brian Murphy

Brian Murphy

Company: Somme Therapeutics

Job title: Chief Executive Officer

Seminars:

Utility of Artificial Intelligence (AI) in Cannabinoid Drug Development 10:15 am

AI can expedite throughput screening AI can expedite receptor modelling AI can draw on prior drug inventories for drug developmentRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.